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INVITED COMMENTARYResponse to commentary on ‘Angiosarcoma as a Potential
Consequence of Autologous Lymph Node Transplantation
for Lymphoedema’
Authors reported the occurrence of angiosarcoma in
a patient with lower limb primary lymphoedema. Two ALNT
were practiced 7 and 14 years before angiosarcoma onset.
Angiosarcoma may occur in patient with primary lymphoe-
dema.1e3 It is possible that angiosarcoma is fortuitous and
not related to previous ALNT.
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Open Surgical Repair and Endovascular Exclusion of
Popliteal Artery Aneurysms”
Although popliteal artery aneurysms (PAA) are the most
common peripheral arterial aneurysms, their incidence is
low, making meaningful observations from single center
series almost impossible due to variations in presentation
and anatomic features. Therefore, retrospective multicenter
registry studies combining the experiences of several
centers, as was performed by Pulli et al.1 have been con-
ducted in an attempt to identify the optimal treatment
options, especially after the adoption of endovascular
popliteal artery aneurysm repairs (EVPAR). The disadvan-
tage of such studies includes the lack of a standardised
protocol for data collection.
Despite the relatively low frequency of PAA, the optimal
treatment requires highly individualized treatment plan-
ning, and is determined by the mode of presentation (acute
vs. nonacute, severity of ischemia, symptomatic vs.
asymptomatic), medical condition, functional capacity andactivity level of the patient, as well as anatomic charac-
teristics (condition of the runoff vessels in the acute and
chronic setting, proximal and distal extent of the aneu-
rysm). Pulli et al. did not make any direct comparisons
between endovascular or open treated patients as they
were signiﬁcantly different from clinical and anatomic
aspects, and their overall outcomes were excellent. The
patients treated with open repair in this series were more
likely to present with acute limb ischemia (ALI), including
patients with the most severe (Rutherford grade 2b)
ischemia, or other chronic symptoms. Unfortunately, they
did not present their patency data separately in patients
who presented acutely from those who were treated
electively, making it harder to evaluate the outcomes
following open repair and EVPAR.
Patients with PAA with ALI are particularly challenging. In
a systematic review of the literature between 1990 and
2008 (895 patients with ALI, Kropman et al.2) there was
a 14.1% amputation rate and no signiﬁcant difference in
amputation rates with or without thrombolysis before
surgery. The authors of the current study have previously
reported better outcomes following successful thrombol-
ysis,3 but patients with more severe ischemia are typically
subjected to open repair. Thrombolysis was used only in
patients who presented with grade I or IIa ischemia in the
current study, which is generally the recommended
approach. However, with the increased availability of hybrid
rooms, and familiarity of surgeons with new thrombectomy
devices (e.g. rheolytic thrombectomy), accelerated throm-
bolysis (e.g. power pulse thrombolysis, US-assisted throm-
bolysis), endovascular recanalization using a combination of
these techniques with early exclusion of the thrombosis
with covered stents followed by “toilet” thrombolysis is
increasingly used, even in patients with advanced ischemia.
This approach can reinstitute blood ﬂow to the extremity
faster than a surgical approach, especially in those with no
target vessels on the initial angiogram.
Due to the risk of secondary embolism being catastrophic
in patients with thrombolysis, primary bypass is preferred
as the initial treatment in patients with a patent artery to
the foot, especially in patients with good autologous vein.
Aulivola et al.4 reported comparable outcomes in patients
with emergent and nonemergent presentations, using
aggressive surgical bypass in patients with distal target
vessels, and utilizing thrombolysis only in those without any
identiﬁable target vessels. Thrombolysis is still used by
many due to reports suggesting that it improves runoff
vessels, while others suggest that it should be reserved for
patients whose clot extends to the trifurcation vessels, with
primary bypass for those with clot that is conﬁned to the
popliteal artery, as one has nothing to gain, but potentially
much to lose if embolization occurs.5
The current report is no exception in reporting the best
outcomes following surgical repair using autologous grafts,
(mainly GSV), with a 48 month primary patency (PP) rate of
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prosthetic grafts and 73% for those who had EVPAR. The
authors also report that prosthetic repair using the poste-
rior approach performed better than the medial approach.
This observation supports excellent published outcomes
following posterior repair,6 although this approach cannot
be used in patients with aneurysms extending to the
adductor canal, or trifurcation vessels. In practical terms, in
patients presenting with elective PAA, the availability of the
GSV and/or feasibility of the posterior approach should be
important determinants when deciding between open and
EVPAR repair.
The authors’ reported PP and secondary patency (SP) of
73% and 85% at 48 months with EVPAR with dual anti-
platelet therapy, and this corresponds to the improving
patency rates in the literature with increased experience,
routine use of clopidogrel, and better endografts. Tielliu
et al.7 reported that the 5-year PP increased to 80% in the
latter part of their study. In a modern series of patients
with symptomatic, nonacute PAA, Idelchik et al.8 reported
88% and 97% PP and SP rates at 3 years in 29 patients (33
limbs). Garg et al.9 reported 86% and 91% PP and SP at 2
years, and 78% and 91% at 4 years in 26 limbs (38%
symptomatic), with no limb loss. A review by these authors
showed a one-year PP of 80e100% in series reported after
2005.
The authors suggest that they are increasingly using
EVPAR in patients with single vessel runoff. This contradicts
their own ﬁnding of poorer runoff independently predicting
poorer PP. Most authors report poorer outcomes in
patients with poor runoff (0e1 vessel runoff), with
reasonable mid-term (even longer term) patency rates with
EVPAR in those with 2e3 vessel runoff and lifelong use of
clopidogrel. Another observation in the current report is
the relatively high acute occlusion rates in patients who
had elective EVPAR compared to those who had open
repair (9.8% vs. 1.5%). This parallels a previous meta-
analysis of 3 studies including 141 patients (37 endovas-
cular; 104 open) by Lovegrove et al.10 reporting increased
30-day graft thrombosis and reintervention rates following
EVPAR.
Due to its less invasiveness (decreased less length of stay
(LOS)) and morbidity, coupled with improved outcomes in
recent years, EVPAR is increasingly being used in good risk
patients with suitable GSV. One important feature that
should be considered before determining the type of repair
is the patients’ daily activities involving prolonged bending
of the knee (such as gardening). It is not uncommon to have
a patient present with an occluded popliteal endograft
following “gardening”, and who is found to have no iden-
tiﬁable abnormalities following thrombolysis. The frequency
of stent fractures (16.7%),11 seen mostly in younger
patients, also suggests that the more active the individual,
the more likely that there will be greater strain on the
stents.
The optimal treatment for patients who need non-
emergent EVPAR remains to be determined. In my
opinion, the only subgroup of patients in whom a trueclinical equipoise exists for a large randomized trial are good
medical risk patients who do not have acute limb ischemia,
have 2e3 vessel runoff, who are willing to take lifelong
clopidogrel, be constantly attentive to not performing
activities involving prolonged bending of the knees, who
also have good veins, and are candidates for an in-line
posterior repair. Considering the small number of patients
with popliteal aneurysms, it is not a realistic expectation to
expect such a randomized trial to be performed with
adequate power, and therefore patients ﬁtting the above
criteria should be very well informed of the risks and
beneﬁts of each treatment modality before proceeding with
repair. All patients with ALI will continue to be treated in
a highly individualized manner, based not only on clinical,
anatomic and patient factors, but also on the experience
and availability of the surgeon or surgeon/interventionist
teams who are competent in all modalities for optimal
outcomes.
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